| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |